A. Horst

Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor.

G. Emons, C. Gründker, V. Viereck, 2004, European journal of endocrinology.